Kevin Mangum, D.O.

Eikenella corrodens

Eikenella corrodens
114P Anaplasia vs Dysplasia

114P Anaplasia vs Dysplasia
113P How to tell a benign and malignant tumor apart? Differentiation and Anaplasia

113P How to tell a benign and malignant tumor apart? Differentiation and Anaplasia
112P - Nomenclature of benign and malignant cancers, How to name cancers, mixed tumors explained

112P - Nomenclature of benign and malignant cancers, How to name cancers, mixed tumors explained
111P - What is a tumor?, Classification of Neoplasms - Benign and Malignant

111P - What is a tumor?, Classification of Neoplasms - Benign and Malignant
110P - Neoplasia, What is Cancer? Introduction to Neoplasm

110P - Neoplasia, What is Cancer? Introduction to Neoplasm
Parasympathetic division of the Autonomic Nervous System (ANS) - Anatomy and Physiology

Parasympathetic division of the Autonomic Nervous System (ANS) - Anatomy and Physiology
Sympathetic Division of the Autonomic Nervous System (ANS) Anatomy and Physiology, Horner Syndrome

Sympathetic Division of the Autonomic Nervous System (ANS) Anatomy and Physiology, Horner Syndrome
Autonomic Nervous System (ANS) - An overview of anatomy, divisions, receptors, and neurotransmitters

Autonomic Nervous System (ANS) - An overview of anatomy, divisions, receptors, and neurotransmitters
107P Severe Combined Immunodeficiency, Wiskott Aldrich Syndrome

107P Severe Combined Immunodeficiency, Wiskott Aldrich Syndrome
106P- Common Variable Immunodeficiency, Isolated IgA Deficiency, Hyper-IgM and DiGeorge Syndrome

106P- Common Variable Immunodeficiency, Isolated IgA Deficiency, Hyper-IgM and DiGeorge Syndrome
pharm4 - Receptor/Effector and Spare Receptors, Competitive, Irreversible, & chemical Antagonists

pharm4 - Receptor/Effector and Spare Receptors, Competitive, Irreversible, & chemical Antagonists
pharm3 - Drug action, Pharmacokinetic Principles, Pharmacology

pharm3 - Drug action, Pharmacokinetic Principles, Pharmacology
Pharm2 - ED50, LD50, Therapeutic index, margin of safety, partial & full agonist

Pharm2 - ED50, LD50, Therapeutic index, margin of safety, partial & full agonist
Pharm1- What is Pharmacology? Introduction to Pharmacology

Pharm1- What is Pharmacology? Introduction to Pharmacology
105P- What is X-Linked Agammaglobulinemia, XLA, or Bruton Disease?

105P- What is X-Linked Agammaglobulinemia, XLA, or Bruton Disease?
104P - Introduction to primary and secondary Immune deficiency diseases

104P - Introduction to primary and secondary Immune deficiency diseases
103P Polymyositis, Dermatomyositis, Inclusion body myositis, Mixed Connective Tissue Disease

103P Polymyositis, Dermatomyositis, Inclusion body myositis, Mixed Connective Tissue Disease
102P Systemic sclerosis, commonly called scleroderma, CREST syndrome, Raynaud phenomenon

102P Systemic sclerosis, commonly called scleroderma, CREST syndrome, Raynaud phenomenon
101P - What is Sjögren Syndrome?

101P - What is Sjögren Syndrome?
100P - Enteropathic Arthropathy

100P - Enteropathic Arthropathy
99P Psoriatic Arthritis;

99P Psoriatic Arthritis; "pencil in cup" deformity
97P What is Ankylosing Spondylitis?

97P What is Ankylosing Spondylitis?
98P - What is Reiter's Syndrome or Reactive arthritis?

98P - What is Reiter's Syndrome or Reactive arthritis?
96P Introduction to the Seronegative Spondyloarthropathies

96P Introduction to the Seronegative Spondyloarthropathies
95P What is Juvenile Rheumatoid Arthritis, JRA, JIA

95P What is Juvenile Rheumatoid Arthritis, JRA, JIA
94P Pathogenesis of Rheumatoid Arthritis, RA

94P Pathogenesis of Rheumatoid Arthritis, RA
93P What is Rheumatoid Arthritis, RA, morphology, prevalence, pannus, Rheumatoid nodules

93P What is Rheumatoid Arthritis, RA, morphology, prevalence, pannus, Rheumatoid nodules
92P Morphology of Systemic lupus erythematosus, SLE, part 3

92P Morphology of Systemic lupus erythematosus, SLE, part 3
91P Morphology of Systemic lupus erythematosus, SLE, part 2, glomerular disease in SLE

91P Morphology of Systemic lupus erythematosus, SLE, part 2, glomerular disease in SLE